[
    {
        "title": "DOCN Shareholder Alert: Investors with Large Losses Should Contact Robbins LLP for Information About Reco - Benzinga",
        "description": "DOCN Shareholder Alert: Investors with Large Losses Should Contact Robbins LLP for Information About Reco  Benzinga",
        "published date": "Thu, 21 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vcHJlc3NyZWxlYXNlcy8yMy8wOS9nMzQ4MDg1NTMvZG9jbi1zaGFyZWhvbGRlci1hbGVydC1pbnZlc3RvcnMtd2l0aC1sYXJnZS1sb3NzZXMtc2hvdWxkLWNvbnRhY3Qtcm9iYmlucy1sbHAtZm9yLWluZm9ybWF0aW9uLWFib3XSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzQ4MDg1NTM?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "1 Growth Stock Down 81% You Can Buy Now in September 2023 - Nasdaq",
        "description": "1 Growth Stock Down 81% You Can Buy Now in September 2023  Nasdaq",
        "published date": "Thu, 21 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvMS1ncm93dGgtc3RvY2stZG93bi04MS15b3UtY2FuLWJ1eS1ub3ctaW4tc2VwdGVtYmVyLTIwMjPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "LAW INVESTOR NEWS: ROSEN, A LEADING LAW FIRM ... - PR Newswire",
        "description": "LAW INVESTOR NEWS: ROSEN, A LEADING LAW FIRM ...  PR Newswire",
        "published date": "Thu, 21 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi3AFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2xhdy1pbnZlc3Rvci1uZXdzLXJvc2VuLWEtbGVhZGluZy1sYXctZmlybS1lbmNvdXJhZ2VzLWNzLWRpc2NvLWluYy1pbnZlc3RvcnMtd2l0aC1sb3NzZXMtdG8tc2VjdXJlLWNvdW5zZWwtYmVmb3JlLWltcG9ydGFudC1kZWFkbGluZS1pbi1zZWN1cml0aWVzLWNsYXNzLWFjdGlvbi0tbGF3LTMwMTkzNTU2OC5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment - EIN News",
        "description": "U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment  EIN News",
        "published date": "Thu, 21 Sep 2023 12:55:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.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?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]